Barclays share price has jumped in the past few months and is hovering at its highest point since 2007. It...
Read moreCoty Inc. has begun a strategic review of its mass-market beauty business, which houses drugstore staples including CoverGirl, Sally Hansen,...
Read moreIt is a financial juggernaut operating on a scale that defies belief, a money-making and money-burning machine at the very...
Read moreThe surprising strength that characterized the start of September has given way to a palpable sense of fear, as a...
Read moreToyota Motor Corp reported Monday that its global vehicle sales rose for an eighth consecutive month in August, supported by...
Read moreDenmark’s Genmab has agreed to acquire Merus NV, a Nasdaq-listed Dutch biotechnology company, in an all-cash transaction valued at $8...
Read moreEuropean shares edged higher on Monday, lifted by gains in healthcare and technology, as investors weighed the risk of a...
Read moreGSK announced on Monday that Chief Executive Emma Walmsley will step down after nine years in the role, with current...
Read moreTata Capital Ltd. is preparing India’s biggest share sale of 2025, with its initial public offering seeking to raise up...
Read moreAstraZeneca announced plans to change how it lists shares in the United States by moving from American depositary receipts (ADRs)...
Read moreDisclaimer: EarningsMastery.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.